The functional study demonstrated that upon NVP treatment, the inhibition of EphB4 kinase activity can inhibit the aggressive behavior in shPDCD10 GBM cells, as well as hinder rapid tumor formation and proliferation, thereby leading to a reduction of the tumor mass in PDCD10 knockdown tumor. The gene discussed is PDCD10; the disease is glioblastoma.